Cipla posted numbers lower than expected for 3QFY2017. The company reported sales of Rs3,550cr v/s Rs3,737cr expected, registering a yoy growth of 15.6%, mainly aided by domestic formulations. Domestic at Rs1,408cr registered a yoy growth of 19.1%, while exports at Rs2,239cr posted yoy growth of 13.7%. On operating front, the EBITDA margi..